HYDROmorphone HCL in 0 recalled over sterility concerns
- Recall date
- May 18, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- SCA Pharmaceuticals recalls HYDROmorphone HCL in 0.9% Sodium Chloride injectable, 0.2 mg per ml, Total Volume 100mL, Single Dose Container bag, (To…
- Recall number
- D-0875-2017
- FDA classification
- Class II
- Brand / firm
- SCA Pharmaceuticals
- Sold / distributed
- Nationwide in the USA
Why it was recalled
Lack of assurance of sterility: Product bags leaking at seam.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
HYDROmorphone HCL in 0.9% Sodium Chloride injectable, 0.2 mg per ml, Total Volume 100mL, Single Dose Container bag, (Total HYDROmorphone Dose 20 mg per 100 mL) Preservative Free, Rx Only, SCA Pharmaceuticals, 8821 Knoedl Ct. Little Rock, AR 72205, NDC 70004-0300-55
Get recall alerts
Free email alert whenever SCA Pharmaceuticals has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: SCA Pharmaceuticals